NCT02671539View on ClinicalTrials.gov

THOR - Tübingen Choroideremia Gene Therapy Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Choroideremia
Interventions
GENETIC

rAAV2.REP1

single subretinal injection

Trial Locations (1)

72076

University Hospital Tuebingen, Center for Ophthalmology, Tübingen

All Listed Sponsors
collaborator

University Hospital Tuebingen

OTHER

lead

STZ eyetrial

OTHER

NCT02671539 - THOR - Tübingen Choroideremia Gene Therapy Trial | Biotech Hunter | Biotech Hunter